Reaction Biology Europe GmbH

Reaction Biology is a multinational contract research organization focused on the discovery of new drugs. Our international team of experienced Ph.D.-degree scientists supports research in all phases of preclinical drug discovery from target validation through hit identification, hit to lead, and lead optimization phases either on a fee-for-service basis or as an integrated partner. Our global service portfolio covers more than 1,000 targets with a strong focus on kinase and epigenetic drug screening. Reaction Biology’s expertise includes services to conduct biochemical, biophysical, cell-based, and animal studies for subcontracted cutting edge drug discovery projects. As a supplier of world-class ProQinase™ recombinant kinase and epigenetic enzymes, we also do support internal drug development activities.



Our commitment is quality support and quality data.
Let’s discover together.